Readoutin 13d
Galderma R&D — Trifarotene
Phase 3 primary completion: A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris.
- Date
- Dec 2026
- Type
- Readout
- Indication
- Acne Vulgaris